CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,573,000 | +36.2% | 10,300,000 | 0.0% | 2.40% | +56.5% |
| Q2 2023 | $112,785,000 | +25.6% | 10,300,000 | 0.0% | 1.53% | +14.9% |
| Q1 2023 | $89,816,000 | +39.1% | 10,300,000 | 0.0% | 1.33% | +38.0% |
| Q4 2022 | $64,581,000 | +79.1% | 10,300,000 | 0.0% | 0.96% | +44.9% |
| Q3 2022 | $36,050,000 | +18.6% | 10,300,000 | 0.0% | 0.67% | +11.0% |
| Q2 2022 | $30,385,000 | -5.1% | 10,300,000 | 0.0% | 0.60% | +2.6% |
| Q1 2022 | $32,033,000 | -8.0% | 10,300,000 | 0.0% | 0.58% | -1.3% |
| Q4 2021 | $34,814,000 | -7.4% | 10,300,000 | 0.0% | 0.59% | +0.3% |
| Q3 2021 | $37,595,000 | -16.3% | 10,300,000 | 0.0% | 0.59% | -24.3% |
| Q2 2021 | $44,908,000 | -4.0% | 10,300,000 | 0.0% | 0.78% | -3.3% |
| Q1 2021 | $46,762,000 | -20.9% | 10,300,000 | 0.0% | 0.81% | -20.6% |
| Q4 2020 | $59,122,000 | -20.7% | 10,300,000 | 0.0% | 1.02% | -3.9% |
| Q3 2020 | $74,572,000 | +307.0% | 10,300,000 | +96.2% | 1.06% | +192.5% |
| Q2 2020 | $18,323,000 | +125.1% | 5,250,000 | -4.5% | 0.36% | +31.6% |
| Q1 2020 | $8,140,000 | -24.5% | 5,500,000 | 0.0% | 0.28% | -13.2% |
| Q4 2019 | $10,780,000 | -22.0% | 5,500,000 | +103.7% | 0.32% | -45.1% |
| Q3 2019 | $13,824,000 | -28.5% | 2,700,000 | 0.0% | 0.58% | -13.6% |
| Q2 2019 | $19,332,000 | +100.8% | 2,700,000 | +272.4% | 0.67% | +60.6% |
| Q1 2019 | $9,628,000 | -44.1% | 725,000 | -43.5% | 0.42% | -37.2% |
| Q2 2018 | $17,209,000 | – | 1,282,374 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |